The Beauty Industry Is Retiring “Anti-Aging.” Longevity Skincare Is What Comes Next.

Fashion & Cosmetics | May 25, 2026

The $65.78 billion skincare industry is abandoning the term “anti-aging,” and the shift is not merely semantic. Longevity skincare, a category built around cellular renewal, mitochondrial support, and preventative maintenance rather than reactive correction, has moved from niche positioning to the dominant framing across prestige beauty in 2026, reshaping both the ingredients brands are sourcing and the customers they are targeting.

The change reflects a broader cultural and scientific moment. Research into the biology of aging has accelerated, bringing laboratory compounds into cosmetic formulations faster than at any previous point in the industry’s history. Consumers, particularly younger ones, are engaging with that science and adjusting their purchasing decisions accordingly. And major houses, from Chanel to Lancôme to South Korea’s most influential export brands, are reconfiguring their hero products around the new language.

What Changed and Why

The term “anti-aging” has been under pressure in the industry for several years, criticised for positioning aging as a problem to be fought rather than a biological process to be supported. But the shift now underway is not primarily about language. It reflects a substantive change in what the most effective formulations are actually doing.

Traditional anti-aging skincare worked largely on the surface: smoothing lines through filler ingredients, brightening through exfoliation, shielding through SPF. Longevity skincare works, at least in theory, at the cellular level. The focus is on supporting the mechanisms by which skin cells produce energy, repair DNA damage, and renew themselves, processes that slow as people age and that can, according to a growing body of dermatological research, be meaningfully supported through topically applied active ingredients.

The central ingredient in this shift is NAD+, or nicotinamide adenine dinucleotide, a coenzyme involved in cellular energy production. NAD+ levels decline with age, and the research case for supplementing them, both orally and topically, has strengthened considerably over the past three years. The challenge for cosmetic chemists is stability: pure NAD+ degrades quickly and is difficult to preserve in a topical formula. The solution most brands have settled on is NMN, or nicotinamide mononucleotide, a precursor that the skin converts into NAD+ more efficiently than the coenzyme itself.

Alongside NAD+ support, leading formulations in 2026 are incorporating PDRN (polydeoxyribonucleotide), a compound derived from salmon DNA that has been used in medical aesthetics for wound healing and is now appearing in over-the-counter skincare. Mitochondrial peptides, exosome therapies, and advanced nanotechnology delivery systems are also present in the more premium tier of the market, though their efficacy at the concentrations available in retail products remains an open question among dermatologists.

What Major Brands Are Launching

The May 2026 beauty calendar reflects the pivot in full. Lancôme’s Longevity Cream, positioned as the brand’s flagship longevity-focused treatment, draws on cellular renewal research and has been one of the month’s most-discussed prestige launches. Chanel added to its Hydra Beauty line with the Micro Gel Crème, a formulation that uses microfluidic technology to preserve white camellia extract within micro-bubbles that release on application, targeting the sustained delivery problem that has limited earlier topical actives.

Obagi’s Nu-Gen Cellular Renewal Serum takes a more science-forward approach, combining NAD+ technology with the brand’s Age Ctrl Complex to address cellular renewal alongside more visible concerns including dullness, fine lines, and redness. Laneige, the South Korean brand whose Water Bank franchise has built a substantial following in Western markets, launched a UV Barrier Sunscreen that combines SPF50+ protection with its Blue Hyaluronic Acid technology, reflecting the view that sun protection is itself a longevity intervention.

K-Beauty’s influence on this category deserves specific attention. South Korean skincare has been driving ingredient innovation in the global market for over a decade, and in 2026 it is among the most aggressive forces behind the longevity framework. Knok Global’s analysis of K-Beauty trends identifies skin longevity as a “mega-trend replacing anti-aging,” with South Korean brands moving the conversation toward long-term skin health metrics rather than short-term visible improvements.

The Consumer Who Is Driving This

Dermatologists and market analysts agree on one aspect of this shift: the customer who has most enthusiastically adopted longevity skincare is younger than the one who drove the anti-aging category for the past two decades.

Consumers in their twenties and early thirties are now approaching skincare as preventative infrastructure rather than corrective treatment. They are reading ingredient lists, following dermatologists on social media, and making purchasing decisions informed by research rather than brand authority alone. That consumer is not looking for products that reverse visible signs of aging. They are looking for products that slow the underlying biological processes before visible signs appear.

This has meaningful implications for how brands position their products. The anti-aging category was built on a visible before-and-after. The longevity category is, almost by definition, built on outcomes that are difficult to photograph and slow to materialise. That creates a marketing challenge: how do you sell prevention when the success condition is the absence of a problem?

The answer most brands have settled on is science communication. The more sophisticated longevity launches of 2026 come with detailed explanatory content about the cellular mechanisms the formulas are designed to support. Consumers who have spent time understanding how NAD+ depletion affects cellular energy are not going to be satisfied with generic “firming” claims.

How Big the Longevity Skincare Market Is Getting

The numbers behind this shift are substantial. The anti-aging market, now being absorbed into the broader longevity skincare category, was estimated at $65.78 billion in 2026 and is projected to reach $151.23 billion by 2035, a compound annual growth rate of 9.69 percent. That growth is not simply the existing market growing. It is a market expanding as younger consumers enter a category that historically skewed toward consumers over 40.

That expansion has not gone unnoticed in the broader wellness and nutrition industry. Supplement brands with NAD+ and NMN products have been pointing to the topical skincare momentum as corroborating evidence for their own product claims, and a handful of brands have begun bridging the two categories, offering oral supplement and topical treatment regimes designed to work in combination.

Whether the science will ultimately support everything being sold in the longevity skincare category is a separate question. The clinical evidence for topical NAD+ delivery remains preliminary, and the concentrations available in retail products are often far below the levels tested in laboratory settings. But the category’s commercial trajectory does not appear to be waiting for that debate to be resolved.

Sources: Longevity Skincare Revolution, Spherical Insights | 2026 Skincare Trends, Who What Wear | Top Skincare Trends for 2026, Korean Skincare Coach | Best New Beauty Products May 2026, NewBeauty | Skin Longevity K-Beauty Trend, Knok Global